Circulation Research:白细胞介素-6预测颈动脉斑块的严重程度、易损性和进展

2022-06-18 MedSci原创 MedSci原创

循环IL-6水平可预测颈动脉斑块的严重程度、易损性和进展。以2.0pg/mL临界值可以帮助识别可以从抗IL-6药物进行脑卒中预防治疗中受益的个体。

白细胞介素-6(IL-6)在动脉粥样硬化的病理生理过程中具有重要作用。

为了明确抗IL-6治疗是否可以作为颈动脉粥样硬化患者的卒中预防策略,近日,心血管领域权威杂志Circulation Research上发表了一篇研究文章,研究人员在以前瞻性人群为基础的心血管健康研究(CHS)中,评估循环IL-6水平是否可以预测颈动脉斑块的严重程度、易损程度和进展。

研究人员分别在基线和5年时对受试者进行了颈动脉超声检查。根据北美症状性颈动脉内膜切除术试验的狭窄程度评分,研究人员将受试者基线斑块严重程度评分为0-5分。斑块易损性是指存在明显不规则形状、溃疡或回声斑块。斑块进展5年后,狭窄程度增加≥1分。研究人员采用多变量线性(严重程度)或logistic(易损性和进展)回归建模来评估基线血浆IL-6水平与斑块特征之间的关系。此外,研究人员将动脉粥样硬化危险因素作为自变量。为了评估模型的稳定性,研究人员计算了未测量的混杂因子与log IL-6的关联的e值或最小强度(比值比量表)。

4334名受试者数据完整(58.9%为女性,平均年龄为72.7±5.1岁),其中1267名(29.2%)患者为易损斑块,1474名(34.0%)患者存在斑块进展。Log IL-6可预测斑块的严重程度(β=0.09,P=1.3×10−3)、易损性(OR为1.21[95%CI为1.05-1.40];P=7.4×10−3,E值=1.71)和进展(OR为1.44[95%CI为1.23-1.69],P=9.1×10−6,E值=2.24)。在斑块进展预测几率超过50%的参与者中,IL-6的平均log为0.54,对应浓度为2.0pg/mL。IL-6水平的二分法不影响预测模型的性能。

由此可见,循环IL-6水平可预测颈动脉斑块的严重程度、易损性和进展。以2.0pg/mL临界值可以帮助识别可以从抗IL-6药物进行脑卒中预防治疗中受益的个体。

原始出处:

Joseph Kamtchum-Tatuene,et al.Interleukin-6 Predicts Carotid Plaque Severity, Vulnerability, and Progression.Circulation Research.2022.https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.122.320877

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2108422, encodeId=3ba5210842240, content=持续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhYfKY2EibXof63P90wFzicRLGZB5xc8szL5iaksERlBHwbicehicvd4wqCCzC4YheUXDLXSxayKwPV22w/0, createdBy=5c0f2120208, createdName=lily_liu_12, createdTime=Sun Jan 01 17:08:27 CST 2023, time=2023-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1843660, encodeId=6c43184366021, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Wed Oct 26 14:19:55 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280800, encodeId=1279128080062, content=<a href='/topic/show?id=c6ba1005490e' target=_blank style='color:#2F92EE;'>#颈动脉斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100549, encryptionId=c6ba1005490e, topicName=颈动脉斑块)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330239, encodeId=6b0313302390e, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557881, encodeId=9731155e8815b, content=<a href='/topic/show?id=d2601533982' target=_blank style='color:#2F92EE;'>#Research#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15339, encryptionId=d2601533982, topicName=Research)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ab14929432, createdName=yangshch, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620622, encodeId=a8051620622ed, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71714, encryptionId=25a4e1714f0, topicName=白细胞介素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=)]
    2023-01-01 lily_liu_12 来自北京

    持续关注

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2108422, encodeId=3ba5210842240, content=持续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhYfKY2EibXof63P90wFzicRLGZB5xc8szL5iaksERlBHwbicehicvd4wqCCzC4YheUXDLXSxayKwPV22w/0, createdBy=5c0f2120208, createdName=lily_liu_12, createdTime=Sun Jan 01 17:08:27 CST 2023, time=2023-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1843660, encodeId=6c43184366021, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Wed Oct 26 14:19:55 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280800, encodeId=1279128080062, content=<a href='/topic/show?id=c6ba1005490e' target=_blank style='color:#2F92EE;'>#颈动脉斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100549, encryptionId=c6ba1005490e, topicName=颈动脉斑块)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330239, encodeId=6b0313302390e, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557881, encodeId=9731155e8815b, content=<a href='/topic/show?id=d2601533982' target=_blank style='color:#2F92EE;'>#Research#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15339, encryptionId=d2601533982, topicName=Research)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ab14929432, createdName=yangshch, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620622, encodeId=a8051620622ed, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71714, encryptionId=25a4e1714f0, topicName=白细胞介素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2108422, encodeId=3ba5210842240, content=持续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhYfKY2EibXof63P90wFzicRLGZB5xc8szL5iaksERlBHwbicehicvd4wqCCzC4YheUXDLXSxayKwPV22w/0, createdBy=5c0f2120208, createdName=lily_liu_12, createdTime=Sun Jan 01 17:08:27 CST 2023, time=2023-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1843660, encodeId=6c43184366021, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Wed Oct 26 14:19:55 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280800, encodeId=1279128080062, content=<a href='/topic/show?id=c6ba1005490e' target=_blank style='color:#2F92EE;'>#颈动脉斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100549, encryptionId=c6ba1005490e, topicName=颈动脉斑块)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330239, encodeId=6b0313302390e, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557881, encodeId=9731155e8815b, content=<a href='/topic/show?id=d2601533982' target=_blank style='color:#2F92EE;'>#Research#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15339, encryptionId=d2601533982, topicName=Research)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ab14929432, createdName=yangshch, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620622, encodeId=a8051620622ed, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71714, encryptionId=25a4e1714f0, topicName=白细胞介素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2108422, encodeId=3ba5210842240, content=持续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhYfKY2EibXof63P90wFzicRLGZB5xc8szL5iaksERlBHwbicehicvd4wqCCzC4YheUXDLXSxayKwPV22w/0, createdBy=5c0f2120208, createdName=lily_liu_12, createdTime=Sun Jan 01 17:08:27 CST 2023, time=2023-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1843660, encodeId=6c43184366021, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Wed Oct 26 14:19:55 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280800, encodeId=1279128080062, content=<a href='/topic/show?id=c6ba1005490e' target=_blank style='color:#2F92EE;'>#颈动脉斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100549, encryptionId=c6ba1005490e, topicName=颈动脉斑块)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330239, encodeId=6b0313302390e, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557881, encodeId=9731155e8815b, content=<a href='/topic/show?id=d2601533982' target=_blank style='color:#2F92EE;'>#Research#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15339, encryptionId=d2601533982, topicName=Research)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ab14929432, createdName=yangshch, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620622, encodeId=a8051620622ed, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71714, encryptionId=25a4e1714f0, topicName=白细胞介素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2108422, encodeId=3ba5210842240, content=持续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhYfKY2EibXof63P90wFzicRLGZB5xc8szL5iaksERlBHwbicehicvd4wqCCzC4YheUXDLXSxayKwPV22w/0, createdBy=5c0f2120208, createdName=lily_liu_12, createdTime=Sun Jan 01 17:08:27 CST 2023, time=2023-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1843660, encodeId=6c43184366021, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Wed Oct 26 14:19:55 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280800, encodeId=1279128080062, content=<a href='/topic/show?id=c6ba1005490e' target=_blank style='color:#2F92EE;'>#颈动脉斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100549, encryptionId=c6ba1005490e, topicName=颈动脉斑块)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330239, encodeId=6b0313302390e, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557881, encodeId=9731155e8815b, content=<a href='/topic/show?id=d2601533982' target=_blank style='color:#2F92EE;'>#Research#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15339, encryptionId=d2601533982, topicName=Research)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ab14929432, createdName=yangshch, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620622, encodeId=a8051620622ed, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71714, encryptionId=25a4e1714f0, topicName=白细胞介素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=)]
    2022-06-20 yangshch
  6. [GetPortalCommentsPageByObjectIdResponse(id=2108422, encodeId=3ba5210842240, content=持续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhYfKY2EibXof63P90wFzicRLGZB5xc8szL5iaksERlBHwbicehicvd4wqCCzC4YheUXDLXSxayKwPV22w/0, createdBy=5c0f2120208, createdName=lily_liu_12, createdTime=Sun Jan 01 17:08:27 CST 2023, time=2023-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1843660, encodeId=6c43184366021, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Wed Oct 26 14:19:55 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280800, encodeId=1279128080062, content=<a href='/topic/show?id=c6ba1005490e' target=_blank style='color:#2F92EE;'>#颈动脉斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100549, encryptionId=c6ba1005490e, topicName=颈动脉斑块)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330239, encodeId=6b0313302390e, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557881, encodeId=9731155e8815b, content=<a href='/topic/show?id=d2601533982' target=_blank style='color:#2F92EE;'>#Research#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15339, encryptionId=d2601533982, topicName=Research)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ab14929432, createdName=yangshch, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620622, encodeId=a8051620622ed, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71714, encryptionId=25a4e1714f0, topicName=白细胞介素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jun 20 10:19:55 CST 2022, time=2022-06-20, status=1, ipAttribution=)]

相关资讯

Neurol Neuroimmunol Neuroinflamm:组织谷氨酰胺酶表达与多发性硬化的进展有关

PBMCs来源的TG2 mRNA水平与多发性硬化疾病进展的临床和放射学测量相关,因此有望作为多发性硬化特别是PP多发性硬化患者疾病进展的生物标志物。

盘点:近期肾病进展(十)

肾脏的生理功能主要是排泄代谢产物及调节水、电解质和酸碱平衡,分泌多种活性物质,维持机体内环境稳定,以保证机体的正常生理功能。肾炎是由免疫介导的、炎症介质(如补体、细胞因子、活性氧等)参与的,最后导致肾

盘点:近期前列腺疾病研究(十)

前列腺是男性生殖器附属腺中最大的实质性器官。由前列腺组织和肌组织构成。前列腺炎是指由多种复杂原因引起的,以尿道刺激症状和慢性盆腔疼痛为主要临床表现的前列腺疾病。前列腺炎是泌尿外科的常见病,在泌尿外科5

盘点:近期膀胱疾病进展(十)

膀胱是一个储尿器官。在哺乳类,它是由平滑肌组成的一个囊形结构,位于骨盆内,其后端开口与尿道相通。膀胱与尿道的交界处有括约肌,可以控制尿液的排出。膀胱为锥体形囊状肌性器官,位于小骨盆腔的前部。膀胱癌是指

Prostate:Vinculin通过调节肿瘤细胞的入侵、迁移和增殖来协调前列腺癌的进展

前列腺癌(PCa)是导致男性死亡的主要原因,仍旧需要进一步开发有效治疗PCa的治疗方法。

Eur Urol:放疗复发的高风险前列腺癌的临床进展模式

超过50%的高风险前列腺癌男性患者 (HRPCa)(格里森4-5级疾病,或者临床T分期3-4级或前列腺特异性抗原(PSA)>20ng/ml)在长期随访中会出现生化复发(BCR)。放疗(RT)后的